Novel Biological Scaffolds – biologics discovery solutions
Isogenica has collaborated with a number of partner companies in the development of novel biotherapeutic scaffolds.
We have used our CIS display and in-house expertise to help optimise these novel scaffolds, and subsequently use the optimised scaffold library in the discovery of novel binding agents which have the potential to be next generation biotherapeutics or diagnostics.
CIS display is robust and easy to operate and together with next generation sequencing to mine outputs, offers a powerful way to interrogate these scaffold libraries.
To take advantage of CIS display and other Isogenica proprietary technologies in the development of your scaffold, why not contact us?
Optimisation of novel biological scaffolds
Selection of new biotherapeutics